The invention provides a novel class of cyclic oximes of Formula I: ##STR00001## wherein A, X, Y, Z, W, R.sub.1, R.sub.2, R.sub.3 and n are as described in the summary of the invention; useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction.

 
Web www.patentalert.com

< Useful energy product

< Frequency selective passive component networks for implantable leads of active implantable medical devices utilizing an energy dissipating surface

> Polymeric fluorescent chemical sensor

> Self-assembling peptides incorporating modifications and methods of use thereof
~ 00608